one) and Drug Interactions (7)]. The risk of hypoglycemia could possibly be reduced by a reduction within the dose of sulfonylurea (or other concomitantly administered insulin secretagogue) or insulin. Notify clients utilizing these concomitant prescription drugs of the risk of hypoglycemia and educate them within the signs and symptoms of hypoglyc